Anita Zaidi had resisted becoming a paediatrician like her mother, "but that changed when I realised the pure joy that I got from healing children", she tells *The Lancet Infectious Diseases*. Ever since, her career has maintained a strong focus on maternal, child, and newborn health. Today, she is director of the vaccine development, surveillance, and enteric and diarrhoeal diseases programs at the Bill & Melinda Gates Foundation (BMGF).

Raised mostly in Karachi, her medical training at the city\'s Aga Khan University (AKU) meant she experienced the problems of both middle-class Pakistan and its poorest communities. Her interest in infections was inspired by her father\'s work with infections in burns victims, and her desire to work in paediatric infectious disease became possible when Claire Panosian, a Professor of Infectious Diseases from University of California, Los Angeles (UCLA) invited Zaidi for an elective experience at UCLA. "The HIV epidemic was beginning to accelerate everywhere then", Zaidi recalls. "It was so formative to work with doctors and patients during this incredibly difficult era."

With the idea to always return to Pakistan, Zaidi set about improving her skills in clinical paediatrics, infections in children, modelling, and epidemiology. She spent a decade in the USA, with training at Duke University, Boston Children\'s Hospital, and Harvard School of Public Health. Then in 2000, she returned with husband Saad Shafqat to Pakistan to raise their two young children, before establishing a new paediatric infectious diseases specialty at AKU.

Zaidi then secured a WHO grant to conduct a study that established *Haemophilus influenzae* type b (Hib) infection was a major problem in Pakistan, causing 20 000 deaths annually. With support from GAVI, she helped Pakistan become the first developing country in Asia to include Hib in its vaccination program in 2006. She also addressed other major infectious killers and disablers of children including rotavirus diarrhoea, pneumococcal meningitis and pneumonia, typhoid, and polio. Zaidi\'s work in finding solutions for identifying and managing newborns with serious infections in community settings became globally recognised, leading to WHO guidelines for low-income settings.

Support from the US National Institutes of Health\'s Fogarty International Center allowed Zaidi to establish paediatric infectious diseases as a speciality in Pakistan with an extensive multidisciplinary training programme that has produced many gifted researchers. Meanwhile, Zaidi herself became the university\'s first ever female chair of paediatrics.

In 2013 she was recruited by BMGF, joining as director of the enteric and diarrhoeal diseases programmes. She has funded partners to develop and introduce rotavirus, typhoid, and cholera vaccines in developing countries worldwide. She has supported Andrew Pollard\'s studies in Oxford for the development of a typhoid vaccine that could be used in children under 2 years and thus in routine vaccination programmes. This vaccine, now with prequalified approval from WHO and financing from GAVI, is being rolled out in several countries, including Pakistan, Zimbabwe, and Liberia.

In 2017, she also started overseeing the vaccine development and surveillance programmes at BMGF beyond enteric diseases. She has supported the establishment of an epidemic preparedness and control team at BMGF, helping launch the Coalition for Epidemic Preparedness Innovations, which is currently intensely accelerating efforts to create a successful vaccine to tackle COVID-19. "Vaccine manufacturers with global donor support are compressing a timeline that is usually 5 to 10 years into 1 to 2 years", explains Zaidi. "These vaccines will need to have equitable access for people in every part of the world, regardless of ability to pay. All the major governments and organisations worldwide are coming together to work as quickly as possible."

Elsewhere, she is also working with colleague Scott Dowell and Emory University on the Child Health and Mortality Prevention Surveillance initiative, that conducts minimally invasive autopsies in seven developing countries in Asia and Africa to give more accurate data on causes of preventable deaths in children. Another area of focus has been on understanding and addressing biological and social vulnerabilities encountered by women and their babies during the course of pregnancy, childbirth and the newborn period.

Zaidi is committed to seeing more women in leadership positions in global health, and with Melinda Gates\' support has sponsored the launch of WomenLift Health, a leadership training program for high-potential mid-career women in countries around the world.

"Anita Zaidi effuses with her determination to make a difference, and with plenty of good humour, drives her passion for improving human health that inspires others to do better", says Pollard. "She is prepared to be tough when it is needed, but uses the natural warmth of her personality, and the clarity of her vision for child health, to bring a leadership at the BMGF that allows her to advance causes across social, regional, and cultural barriers."
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